Get started
Author

G. L. Pearce

Observed names: G L Pearce, G Pearce, G. L. PEARCE, G. Pearce, G.L. Pearce
OpenAlex ID: A5111379153
The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England
1998 · L. V. Wilton, G. L. Pearce, et al. · BJOG An International Journal of Obstetrics & Gynaecology · 142
Adverse effects associated with the use of donepezil in general practice in England
2000 · N. R. Dunn, G. L. Pearce, et al. · Journal of Psychopharmacology · 116
A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies
1996 · L. V. WILTON, G. L. PEARCE, et al. · British Journal of Clinical Pharmacology · 112
PDF
Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring.
1988 · W. H. Inman, N. S. Rawson, et al. · BMJ · 111
PDF
Prescriber profile and post-marketing surveillance
1993 · W. Inman, G. Pearce · The Lancet · 79
The safety of finasteride used in benign prostatic hypertrophy: a non‐interventional observational cohort study in 14 772 patients
1996 · L. Wilton, G. Pearce, et al. · British Journal of Urology · 70
Safety of fluconazole in the treatment of vaginal candidiasis
1994 · W. Inman, G. Pearce, et al. · European Journal of Clinical Pharmacology · 62
Newer antidepressants: a comparison of tolerability in general practice.
1999 · F R Mackay, N R Dunn, et al. · Europe PMC (PubMed Central) · 53
The safety of risperidone: a post-marketing study on 7684 patients
1998 · F. J. Mackay, L. V. Wilton, et al. · Human Psychopharmacology Clinical and Experimental · 43
Mutations in HIV-1 Reverse Transcriptase during Therapy with Abacavir, Lamivudine and Zidovudine in HIV-1-Infected Adults with No Prior Antiretroviral Therapy
2002 · Mounir Ait-Khaled, Abdelrahim Rakik, et al. · Antiviral Therapy · 39
PDF
Tenofovir disoproxil fumarate in pregnancy and prevention of mother‐to‐child transmission of HIV‐1: is it time to move on from zidovudine?
2009 · C Foster, H Lyall, et al. · HIV Medicine · 38
A comparison of two cohort studies evaluating the safety of cisapride: Prescription-Event Monitoring and a large phase IV study
1997 · E. Wager, P. J. H. Tooley, et al. · European Journal of Clinical Pharmacology · 33
The pharmacovigilance of tamsulosin: event data on 12 484 patients
2000 · R.D. Mann, P. Biswas, et al. · British Journal of Urology · 31
Losartan: a study of pharmacovigilance data on 14 522 patients
1999 · RD Mann, F Mackay, et al. · Journal of Human Hypertension · 30
Prescription‐event monitoring (PEM) in 1996—a method of non‐interventional observational cohort pharmacovigilance
1997 · R. D. Mann, L. V. Wilton, et al. · Pharmacoepidemiology and Drug Safety · 30
United Kingdom experience with alendronate and oesophageal reactions.
1998 · F J Mackay, L V Wilton, et al. · Europe PMC (PubMed Central) · 27
ACE-inhibitor-induced cough, an adverse drug reaction unrecognised for several years: studies in Prescription-Event Monitoring
1996 · K. Kubota, N. Kubota, et al. · European Journal of Clinical Pharmacology · 22
Vasodilation-related adverse events in diltiazem and dihydropyridine calcium antagonists studied by prescription-event monitoring
1995 · K. Kubota, G.L. Pearce, et al. · European Journal of Clinical Pharmacology · 21
Finasteride and tamsulosin used in benign prostatic hypertrophy: a review of the prescription‐event monitoring data
2001 · S. Shakir, G. Pearce, et al. · British Journal of Urology · 13
Pharmacosurveillance and safety of the leukotriene receptor antagonist (LTRA), montelukast
2001 · P. Biswas, L. Wilton, et al. · Clinical & Experimental Allergy Reviews · 8
Angiotensin converting enzyme inhibitors and asthma
1994 · W H W Inman, L Wilton, et al. · BMJ · 7
Nefazodone in community use: the results of prescription-event monitoring
1999 · F. J. Mackay, G. L. Pearce, et al. · Pharmacoepidemiology and Drug Safety · 5
Works count: 22
Citation count: 1,092
H-index: 18
I10-index: 19
Year
Topic
Type